Past, present and (foreseeable) future of biological anti-TNF alpha therapy

GM Leone, K Mangano, MC Petralia, F Nicoletti… - Journal of Clinical …, 2023 - mdpi.com
Due to the key role of tumor necrosis factor-alpha (TNF-α) in the pathogenesis of
immunoinflammatory diseases, TNF-α inhibitors have been successfully developed and …

Alopecia areata: a review of disease pathogenesis

F Rajabi, LA Drake, MM Senna… - British Journal of …, 2018 - academic.oup.com
Background Alopecia areata is a disorder that results in nonscarring hair loss. The
psychological impact can be significant, leading to feelings of depression and social …

[HTML][HTML] The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus

A Abdel-Moneim, HH Bakery, G Allam - Biomedicine & Pharmacotherapy, 2018 - Elsevier
Diabetes mellitus (DM) is a serious medical problem affecting millions of peoples worldwide,
and has a great socio-economic impacts. Cytokines possess a pivotal role in modulation of …

Metformin and autoimmunity: a “new deal” of an old drug

F Ursini, E Russo, G Pellino, S D'Angelo… - Frontiers in …, 2018 - frontiersin.org
Metformin (dimethyl biguanide) is a synthetic derivative of guanidine, isolated from the
extracts of Galega officinalis, a plant with a prominent antidiabetic effect. Since its discovery …

Glucocorticoid sensitivity in health and disease

RA Quax, L Manenschijn, JW Koper… - Nature Reviews …, 2013 - nature.com
Glucocorticoids regulate many physiological processes and have an essential role in the
systemic response to stress. For example, gene transcription is modulated by the …

Immune mechanisms in inflammatory anemia

SP Canny, SL Orozco, NK Thulin… - Annual review of …, 2023 - annualreviews.org
Maintaining the correct number of healthy red blood cells (RBCs) is critical for proper
oxygenation of tissues throughout the body. Therefore, RBC homeostasis is a tightly …

Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: From pathogenic factors to therapeutic targets

S Günther, P Fagone, G Jalce, AG Atanasov… - Drug discovery today, 2019 - Elsevier
Highlights•MIF acts cytokine, enzyme, endocrine hormone and chaperon-like molecule.•D-
DT, a member of the MIF family, exerts non-redundant effects from MIF.•MIF and D-DT are up …

MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development

J Bloom, S Sun, Y Al-Abed - Expert opinion on therapeutic targets, 2016 - Taylor & Francis
Introduction: Macrophage migration inhibitory factor (MIF) has emerged as a promising drug
target in diseases including sepsis, rheumatoid arthritis, and cancer. MIF has multiple …

Macrophage migration inhibitory factor (MIF) makes complex contributions to pain-related hyperactivity of nociceptors after spinal cord injury

A Bavencoffe, EA Spence, MY Zhu… - Journal of …, 2022 - Soc Neuroscience
Neuropathic pain is a major, inadequately treated challenge for people with spinal cord
injury (SCI). While SCI pain mechanisms are often assumed to be in the CNS, rodent studies …

MIF as a disease target: ISO-1 as a proof-of-concept therapeutic

Y Al-Abed, S VanPatten - Future medicinal chemistry, 2011 - Taylor & Francis
Macrophage migration inhibitory factor (MIF) is a pleiotropic proinflammatory cytokine that
has been implicated as playing a causative role in many disease states, including sepsis …